ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RSMDF is expected to report earnings to fall 2.18% to 23 cents per share on April 24
Q1'25
Est.
$0.24
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Est.
$0.21
Q1'24
Beat
by $0.02
The last earnings report on January 30 showed earnings per share of 24 cents, beating the estimate of 23 cents. With 750.00K shares outstanding, the current market capitalization sits at 32.67B.